The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according ...

HHS has terminated contracts with Moderna worth more than $700 million that were meant to fund the company’s development of ...

The Health and Human Services Department, led by vaccine skeptic Robert F. Kennedy Jr., has canceled $766 million in payments ...

But some insurers and employers may decide to still cover the shots regardless of the new recommendations, said Jen Kates, a ...

A new variant of COVID-19 is circulating in parts of the world and may be driving an increase in cases in the eastern ...

Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines ...

Dr. Peter McCullough testified Thursday at a Senate hearing on "The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events ...